Renaissance Technologies’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $81K | Buy |
40,500
+15,700
| +63% | +$31.4K | ﹤0.01% | 3332 |
|
2025
Q1 | $62K | Sell |
24,800
-58,900
| -70% | -$147K | ﹤0.01% | 3267 |
|
2024
Q4 | $247K | Sell |
83,700
-106,900
| -56% | -$315K | ﹤0.01% | 3102 |
|
2024
Q3 | $574K | Buy |
190,600
+125,700
| +194% | +$378K | ﹤0.01% | 2726 |
|
2024
Q2 | $226K | Sell |
64,900
-44,900
| -41% | -$156K | ﹤0.01% | 3006 |
|
2024
Q1 | $580K | Buy |
+109,800
| New | +$580K | ﹤0.01% | 2801 |
|
2023
Q1 | – | Sell |
-3,493
| Closed | -$11K | – | 4440 |
|
2022
Q4 | $11K | Sell |
3,493
-121,919
| -97% | -$384K | ﹤0.01% | 4032 |
|
2022
Q3 | $572K | Buy |
125,412
+97,725
| +353% | +$446K | ﹤0.01% | 2848 |
|
2022
Q2 | $731K | Sell |
27,687
-11,596
| -30% | -$306K | ﹤0.01% | 2909 |
|
2022
Q1 | $1.46M | Buy |
+39,283
| New | +$1.46M | ﹤0.01% | 2455 |
|
2021
Q3 | – | Sell |
-3,421
| Closed | -$323K | – | 3880 |
|
2021
Q2 | $323K | Buy |
+3,421
| New | +$323K | ﹤0.01% | 3123 |
|
2021
Q1 | – | Sell |
-27,833
| Closed | -$1.62M | – | 3748 |
|
2020
Q4 | $1.62M | Buy |
27,833
+23,700
| +573% | +$1.38M | ﹤0.01% | 2251 |
|
2020
Q3 | $86K | Buy |
4,133
+3,735
| +938% | +$77.7K | ﹤0.01% | 3232 |
|
2020
Q2 | $6K | Buy |
+398
| New | +$6K | ﹤0.01% | 3384 |
|